ESR1 and breast carcinoma: Recent evidences suggest that AR antagonizes ER function and plays an anti-proliferative role in ER+ve breast cancers whereas it plays a significant role in facilitating tumor cell growth in an androgen-dependent manner in an ER–/AR+ breast cancers [13,15].